- Home
- ELTK vs IXHL Comparison
ELTK vs IXHL Comparison
Compare ELTK & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTK
- IXHL
- Stock Information
- Founded
- ELTK 1970
- IXHL 2001
- Country
- ELTK Israel
- IXHL Australia
- Employees
- ELTK N/A
- IXHL N/A
- Industry
- ELTK Electrical Products
- IXHL
- Sector
- ELTK Technology
- IXHL
- Exchange
- ELTK Nasdaq
- IXHL Nasdaq
- Market Cap
- ELTK 70.4M
- IXHL 78.7M
- IPO Year
- ELTK 1997
- IXHL N/A
- Fundamental
- Price
- ELTK $10.18
- IXHL $0.38
- Analyst Decision
- ELTK
- IXHL
- Analyst Count
- ELTK 0
- IXHL 0
- Target Price
- ELTK N/A
- IXHL N/A
- AVG Volume (30 Days)
- ELTK 9.3K
- IXHL 178.1M
- Earning Date
- ELTK 08-14-2025
- IXHL 09-29-2025
- Dividend Yield
- ELTK 1.87%
- IXHL N/A
- EPS Growth
- ELTK N/A
- IXHL N/A
- EPS
- ELTK 0.45
- IXHL N/A
- Revenue
- ELTK $49,563,000.00
- IXHL $98,000.00
- Revenue This Year
- ELTK $18.60
- IXHL $2,538.49
- Revenue Next Year
- ELTK $9.04
- IXHL $249.95
- P/E Ratio
- ELTK $22.55
- IXHL N/A
- Revenue Growth
- ELTK 6.75
- IXHL N/A
- 52 Week Low
- ELTK $7.65
- IXHL $0.08
- 52 Week High
- ELTK $12.19
- IXHL $3.12
- Technical
- Relative Strength Index (RSI)
- ELTK 46.22
- IXHL 44.52
- Support Level
- ELTK $10.20
- IXHL $0.34
- Resistance Level
- ELTK $10.45
- IXHL $0.57
- Average True Range (ATR)
- ELTK 0.35
- IXHL 0.13
- MACD
- ELTK -0.01
- IXHL -0.05
- Stochastic Oscillator
- ELTK 27.94
- IXHL 4.09
About ELTK Eltek Ltd.
Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. It manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnect, flex-rigid and multi-layered boards. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. Its geographic areas are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.